While many epigenetic effector proteins, such as DNA methyl-transferases or histone deacetylases, are known to be mutated in human cancers, thus directly affecting tumour development20, the indirect inhibition of demethylation via IDH mutation suggests a new role for metabolism in the regulation of the epigenome. The gene discussed is IDH2; the disease is cancer.